| Dr Craig Ladd Olson, MD | |
|
1111 Bayshore Dr, Manitowoc, WI 54220-5548 | |
| (920) 682-6376 | |
| (920) 652-0115 |
| Full Name | Dr Craig Ladd Olson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 36 Years |
| Location | 1111 Bayshore Dr, Manitowoc, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407947450 | NPI | - | NPPES |
| 34634400 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 48033 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora At Home | Green bay, WI | Home health agency |
| Aurora Medical Ctr Manitowoc County | Two rivers, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baycare Clinic Llp | 4385554328 | 185 |
News Archive
Ardea Biosciences, Inc. announced positive, preliminary, top-line results from its Phase 2b monotherapy study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout. In this 28-day, randomized, double-blind, placebo-controlled, dose-escalation study, 123 gout patients with hyperuricemia (serum urate levels greater than or equal to 8 mg/dL) received 200 mg once-daily (qd) RDEA594, 400 mg qd RDEA594, 600 mg qd RDEA594 or matching placebo.
A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to researchers at Washington University School of Medicine in St. Louis.
Anticipating the needs and preferences of current and future gym members, Anytime Fitness announced today that it has purchased PumpOne – a leading mobile personal training services provider featuring the world's largest exercise image and video library.
The Czech company Riocath Global developed and patented in collaboration with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences a world-wide unique technology applicable to tubular medical devices. One of the first clinically significant applications is a new form of urinary catheter.
› Verified 9 days ago
| Entity Name | Baycare Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588609648 PECOS PAC ID: 4385554328 Enrollment ID: O20031105000087 |
News Archive
Ardea Biosciences, Inc. announced positive, preliminary, top-line results from its Phase 2b monotherapy study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout. In this 28-day, randomized, double-blind, placebo-controlled, dose-escalation study, 123 gout patients with hyperuricemia (serum urate levels greater than or equal to 8 mg/dL) received 200 mg once-daily (qd) RDEA594, 400 mg qd RDEA594, 600 mg qd RDEA594 or matching placebo.
A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to researchers at Washington University School of Medicine in St. Louis.
Anticipating the needs and preferences of current and future gym members, Anytime Fitness announced today that it has purchased PumpOne – a leading mobile personal training services provider featuring the world's largest exercise image and video library.
The Czech company Riocath Global developed and patented in collaboration with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences a world-wide unique technology applicable to tubular medical devices. One of the first clinically significant applications is a new form of urinary catheter.
› Verified 9 days ago
| Entity Name | Ascension Calumet Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376541748 PECOS PAC ID: 7416948427 Enrollment ID: O20040809000191 |
News Archive
Ardea Biosciences, Inc. announced positive, preliminary, top-line results from its Phase 2b monotherapy study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout. In this 28-day, randomized, double-blind, placebo-controlled, dose-escalation study, 123 gout patients with hyperuricemia (serum urate levels greater than or equal to 8 mg/dL) received 200 mg once-daily (qd) RDEA594, 400 mg qd RDEA594, 600 mg qd RDEA594 or matching placebo.
A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to researchers at Washington University School of Medicine in St. Louis.
Anticipating the needs and preferences of current and future gym members, Anytime Fitness announced today that it has purchased PumpOne – a leading mobile personal training services provider featuring the world's largest exercise image and video library.
The Czech company Riocath Global developed and patented in collaboration with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences a world-wide unique technology applicable to tubular medical devices. One of the first clinically significant applications is a new form of urinary catheter.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Craig Ladd Olson, MD 1035 Kepler Dr, Green Bay, WI 54311-8320 Ph: (920) 490-9046 | Dr Craig Ladd Olson, MD 1111 Bayshore Dr, Manitowoc, WI 54220-5548 Ph: (920) 682-6376 |
News Archive
Ardea Biosciences, Inc. announced positive, preliminary, top-line results from its Phase 2b monotherapy study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout. In this 28-day, randomized, double-blind, placebo-controlled, dose-escalation study, 123 gout patients with hyperuricemia (serum urate levels greater than or equal to 8 mg/dL) received 200 mg once-daily (qd) RDEA594, 400 mg qd RDEA594, 600 mg qd RDEA594 or matching placebo.
A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to researchers at Washington University School of Medicine in St. Louis.
Anticipating the needs and preferences of current and future gym members, Anytime Fitness announced today that it has purchased PumpOne – a leading mobile personal training services provider featuring the world's largest exercise image and video library.
The Czech company Riocath Global developed and patented in collaboration with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences a world-wide unique technology applicable to tubular medical devices. One of the first clinically significant applications is a new form of urinary catheter.
› Verified 9 days ago
Dr. David James Kuester, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 501 N 10th St, Manitowoc, WI 54220 Phone: 920-682-6376 Fax: 920-682-6778 | |
Michael Patrick Kennedy, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-5251 | |
Dr. Joseph Edgar Trader, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 501 N 10th St, Manitowoc, WI 54220 Phone: 920-682-6376 Fax: 920-682-6778 | |
Dr. David King Mikolyzk, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-5251 Fax: 920-682-2006 | |
Dr. Carl Alan Diraimondo, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1111 Bayshore Dr, Manitowoc, WI 54220 Phone: 920-682-6376 Fax: 920-652-0115 | |
Barry V Bast, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7326 Cr Jj, Manitowoc, WI 54220 Phone: 920-973-3089 Fax: 920-682-0888 |